Maybe the best ⁦Wilmot Cancer Institute⁩ fundraiser of the year! Hot dogs by Presley and Haylee in Nunda NY.

Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: data suggest minimizing steroid dosing. Journal of Clinical Oncology ascopubs.org/doi/abs/10.120…

Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes: Journal of Clinical Oncology ascopubs.org/doi/abs/10.120…

CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro: these data support our enrolling SWOG Cancer Research Network S2114 clinical trial. ashpublications.org/blood/article-…

Hugely important trial results in Journal of Clinical Oncology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Cannabis for Refractory Chemotherapy-Induced Nausea and Vomiting: the applicability and generalizability of the evidence is limited by changes in antiemetic guidelines and availability of THC:CBD. Thoughtful Journal of Clinical Oncology editorial by Dr Zimmermann ascopubs.org/doi/full/10.12…

Ready, AIM, stop: ibrutinib plus venetoclax in MCL. Nice commentary by my Wilmot Cancer Institute colleague Danielle Wallace ashpublications.org/blood/article/…

#WilmotFlashbackFriday to 2013: Who remembers our first-ever Warrior Walk? Back then, about 100 participants came out then to celebrate survivorship & walk the track University of Rochester. Now, the #WilmotWarrior Weekend has hundreds who walk, run & bike! 🚴‍♀️🏃‍♂️ Join us: teamraiser.rochester.edu/site/TR?pg=ent…

New editorial discusses recent RCT published in Journal of Clinical Oncology: Oral cannabis (THC:CBD) extract promising for patients with refractory chemotherapy-induced nausea and vomiting. Further trials needed comparing with other antiemetics, particularly olanzapine. ascopubs.org/doi/10.1200/JC…

Congratulations to Brian Marples, PhD, on becoming a 2024 ASTRO Fellow! View the complete list of the 2024 Fellows here: ow.ly/90Tq50SImtL Brian Marples Wilmot Cancer Institute URochester SMD

New from JCO Journals! We are proud to announce the launch of JCO Oncology Advances. First published articles coming soon.

We can’t wait to welcome you to Wilmot Cancer Institute !

Two inspiring gifts: Presley & Haylee’s Hot Dogs for Wilmot Cancer Institute and Jack Jones All Stars & Golden Thread Acres. So appreciate this support!

Social Genomic Determinants of Health: a concrete biological pathway through which the effects of social processes and social epidemiology come to affect the basic biology of cancer and ultimately clinical outcomes and survival. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

When University of Rochester founded its cancer center 50 years ago, DNA & RNA sequencing was done through gel electrophoresis, barely detecting single genes. Today, Wilmot's Genomics Shared Resource uses a machine that can analyze 250+ genomes weekly. 🤯Amazing! #WilmotFlashbackFriday

Enhancing Precision in Detecting Severe Immune-Related Adverse Events: use of large language models required 9 seconds/chart versus 15 minutes for clinician adjudication and demonstrated higher sensitivity with similar specificity. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

We are excited to share that John Ashton, PhD, MBA, has been named Associate Director for Shared Resources at Wilmot Cancer Institute. Read more about his story & Shared Resources at Wilmot: urmc.rochester.edu/news/story/wil… #URochesterResearch

Incident Melanoma Among Individuals With Low-Count MBL: Susceptibility to melanoma appears to originate from the onset of MBL rather than CLL. If validated, there are implications regarding surveillance strategies for patients with MBL. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

Congrats to Minsoo Kim on this impactful work exploring How the Immune System Fails as Cancer Arises: Wilmot Cancer Institute microenvironment program. urmc.rochester.edu/news/story/res…